disease is difficult to define con-clusively. Research suggests that this association is similar to the association between glycemic control and the classic complications of diabetes such as ret-inopathy and nephropathy. Thus, although poor control of diabetes clearly increases the risk of diabetic complications, there are many poorly controlled diabetic individuals without major complications. 2 Conversely, good control of diabetes greatly decreases the risk of diabetic complications. Periodontal diseases are now recognized as the sixth complication of diabetes mellitus. 3 Although the bulk of oral health-related research pertaining to diabetes has focused on the impact of diabetes on periodontal health, there is also evidence to support the notion that periodontal infections contribute to problems related to glycemic control. A two-way relationship between periodontal disease and diabetes mellitus has been proposed. 4 The biochemical basis where by hyperglycemia may lead to the microvascular complications seen in diabetes is the increased accumulation of advanced glycation end products (AGEs) in the plasma and tissues of diabetic patients. Binding AGE-modified proteins to macrophage receptors initiates a cycle of cytokine upregulation, with synthesis mostly of IL-1 and TNF α. Periodontal inflammation mediated-cytokine synthesis and secretion may amplify the magnitude of the AGE mediated cytokine response and vice-versa.
In a large epidemiologic study in the United States, adults with poorly controlled diabetes had a 2.9-fold increased risk of having periodontitis compared to non-diabetic adult subjects; conversely, well-controlled diabetic subjects had no significant increase in the risk of periodontitis. 5 In a crosssectional study of pa-tients who had type I diabetes for a mean duration of over 16 years, subjects with poor glycemic control had more interproximal attachment loss and bone loss than well-controlled subjects. 3 Similar results have been found in other studies in which the percent-age of deep periodontal pockets and the prevalence of severe attachment loss increased as the glycaemic control worsened. 6, 7 The objective of the present study was to perform a clinical and metabolic comparison of the response to nonsurgical periodontal therapy between type II diabetic patients and non-diabetic patients.
MATERIAL AND METHODS:
A total of 40 patients were enrolled in this clinical study after taking informed consent. The selected patients were divided into two groups, Group I (cases)-consisting of patients diagnosed with type II diabetes with generalized moderate chronic periodontitis and Group II (controls) -consisting of non-diabetics with generalized moderate chronic periodontitis.
The following were criteria for inclusion of these individuals in the study, age group of 35-60 years, presence of type II diabetes, clinical diagnosis of generalized moderate chronic periodontitis defined by loss of clinical attachment of 4-6mm in all quadrants and presence of minimum 10 teeth per arch and no modification in medication in the last 02 months before or during the study. Exclusion criteria were as follows: presence of systemic disease that could influence the course of the periodontal disease, intake of antibiotics or anti-inflammatory drugs in the past 04 weeks before study, current smokers or ex-smokers for < 05 years and pregnancy.
The patients who qualified the study were rescheduled for laboratory, periodontal, and clinical examinations. They underwent an initial examination including a general medical history, and periodontal examination consisting following parameters at baseline and 03 months following scaling and root planing : bleeding on probing, oral hygiene index-simplified (OHI-S), probing depth and clinical attachment level. Probing depth and clinical attachment level were recorded using a Williams periodontal probe at six sites per tooth (mesial, central, and distal; buccally as well as lingually/ palatally) using a customized acrylic stent as a reference to determine the site and angle of measurements, ensuring reproducibility during examinations. Blood samples were taken at baseline and at 03 months recall visit to monitor glycated hemoglobin.
A specific treatment protocol was designed for the study. All patients received standard oral instructions before the first session of scaling and root planing. All patients received scaling and root Effect of non surgical periodontal therapy on glycemic control in patients Vijayalaxmi, et, al. planing in 2 sittings spaced within 24 -36 hours using standard periodontal currettes and ultrasonic device.
STATISTICAL ANALYSIS:
The mean and standard deviation values of the parameters were calculated and grouped per subject per group. The changes in bleeding on probing between the baseline and the 3 month post non surgical periodontal therapy (NSPT) were tested within the treatment groups using Wilcoxon test. The Mann-Whitney test was used to determine significant differences between the groups.
RESULTS:
There is a highly significant difference in the pre treatment and 03 months post NSPT Hb1ac values in group I (p<0.0001), a non significant difference in group II (p>0.05) (Table 1, Figure 1 ). There is no significant difference in the pre treatment and 03 months post NSPT BOP between group I and group II (p>0.05), and a highly significant difference between the pre treatment and 03 months post NSPT BOP in group I and group II (p<0.0001). There is no significant difference in the pre treatment and 03 months post NSPT OHIS scores between group I and group II (p>0.05), and a highly significant difference between the pre treatment and 03 months post NSPT OHIS scores in group I and group II (p<0.0001). There is a highly significant difference in the pre treatment and 03 months post NSPT probing depth values in group I and group II (p<0.0001), and no significant difference between the pre treatment and 03 months post NSPT probing depth values in group I and group II (p>0.05) (Table 2, Figure 2 ).There was no significant difference between the pretreatment and 03 months post NSPT CAL in group I and group II) (Table 3, Figure 3 ].
DISCUSSION:
In the present study, two groups (diabetic and non diabetic) with generalized moderate chronic periodontitis were selected and treated by non surgical periodontal therapy to determine whether there were clinical and laboratory differences between them following periodontal treatment. The results of the present study show that non surgical periodontal treatment of type II diabetic patients with generalized moderate periodontal disease is associated with significant improvement in their glycemic control after 03 months. All the periodontal clinical parameters (BOP, OHI-S, PPD, CAL) were significantly improved in the group I. Results in the literature regarding the influence of periodontal therapy on glycemic control in diabetes are generally contradictory. 8, 9 The effectiveness of periodontal therapy on glycemic control and systemic inflammation is not proven beyond doubt and studies should be interpreted with caution because they may differ in design, population type (type I or II diabetic patients or both)severity, and extent of periodontal disease (healthy, gingivitis and different degrees of periodontitis), length of study period (adequate or not to register variations in HbA1c levels), or treatment type (scaling and root planning alone or associated with use of local and systemic antibiotics in addition to scaling and root planning) among other variables. 10 In the present study, antibiotics were not used as an adjunctive to non-surgical periodontal disease treatment. Administration of antibiotics, especially systemic, can lead to controversial results regarding HbA1C, because they may affect other systemic sources of infection/inflammation and potential reduction in HbA1C levels cannot be solely attributed to the local reduction in the infectious/inflammatory periodontal burden. Furthermore, it is well accepted that HbA1C is affected by systemic inflammation. 11, 12 Most studies examining the effect of periodontal disease treatment in patients with diabetes have incorporated antibiotic administration (topical or systemic). 8, 9 The results of the present study, concerning the glycemic effect of non-surgical periodontal therapy (without any local or systemic antibiotic administration) in diabetes, are in accordance with those of Kiran et al, who on 44 Turkish patients with type 2 diabetes and moderate periodontal disease, showed such treatment provided a statistically significant reduction in periodontal parameters and HbA1C levels after 3 months. 13 The biologic rationale and the mechanisms underlying the effect that periodontal treatment has on glycemic control and chronic inflammation are not clarified completely, but there is evidence to support Effect of non surgical periodontal therapy on glycemic control in patients Vijayalaxmi, et, al. the hypothesis that resolution of inflammation from the periodontal tissues has a favorable effect on HbA1C levels. The present study was not designed to investigate the underlying mechanisms through which periodontal treatment results in improvement of glycemic control. It is clear that more studies are needed to clarify these mechanisms. The small sample size and short follow up period are the major limitations of the present study. Case-control design although provides a higher strength of evidence as compared to other cross-sectional studies, is still laden with biases. In evaluating the clinical significance of the data, it must be remembered that although means are excellent summary statistics, they do not directly relate to what is measurable with a periodontal probe. Further prospective randomized control studies with larger sample size, longer follow up period, different populations and additional biochemical parameters are needed to substantiate our findings generalize them to other populations of patients with type II diabetes.
CONCLUSION:
The present study has demonstrated that non surgical periodontal treatment can improve the periodontal status of patients with type II diabetes and have a favorable effect on glycemic control in these patients.
